http://jcps.bjmu.edu.cn

• Full Papers • Previous Articles     Next Articles

Preparation and characterization of budesonide-loaded solid lipid nanoparticles for pulmonary delivery

Pei-Ran Zhang, Ying-Feng Tu, Shuo Wang, Yi-Hui Wang, Ying Xie*, Miao Li*, Yi-Guang Jin   

  1. 1. Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
    2. School of Pharmaceutics, Basel University, Basel CH-4056, Switzerland
    3. Beijing Institute of Radiation Medicine, Beijing 100850, China
  • Received:2011-01-24 Revised:2011-04-05 Online:2011-07-01 Published:2011-07-01
  • Contact: Ying Xie*, Miao Li*

Abstract:

To increase the solubility and adsorption of budesonide (BUD), budesonide-loaded solid lipid nanoparticles (BUD-SLNs) were prepared and characterized in this study. Glycerin monostearate (GMS) was selected to be the matrix lipid material after calculation the differences of partial solubility parameters. An emulsification-ultrasound diffusion method was employed and formula was optimized in the BUD-SLNs preparation. The entrapment efficiency (ee%) of BUD-SLNs was (97.77±2.60)%, and the mean particle size was 147.3 nm (PDI = 0.228). Uniform and sphere particles were observed under TEM. The in vitro release of BUD-SLNs could be well explained by the biphasic release dynamics equation. The spectrums of DSC and X-ray diffraction indicated that BUD molecules were dispersed mainly into the lipids to form homogeneous matrix structure. Our results provide fundamental data for the application of SLNs in pulmonary delivery system.

Key words: Budesonide, Solid lipid nanoparticles, Pulmonary drug delivery, Preparation, Characterization

CLC Number: 

Supporting: